BioSpace News Archive

Deals

Lundbeck Acquires Abide Therapeutics for $250M, Gains San Diego Discovery Site

With a $250 million cash down payment, Denmark’s H. Lundbeck A/S snapped up San Diego-based Abide Therapeutics to gain a novel discovery platform and a U.S.-based research hub.

May 6, 2019
·
2 min read
·
Alex Keown
Business

Artificial Intelligence is Ramping up in Drug Development

AstraZeneca announced a long-term collaboration deal with BenevolentAI, a UK-based company focused on combining computational medicine and advanced artificial intelligence.This deal only marks one of the most recent AI team-ups announced in the biopharma industry.

May 6, 2019
·
5 min read
·
Mark Terry
Biotech Bay

TLC Highlights Data Presentations on Lead Product Candidate TLC599 at Osteoarthritis Research Society International (OARSI) 2019 World Congress

TLC presented data from numerous recent studies on its lead product candidate, TLC599, at the Osteoarthritis Research Society International World Congress, which took place May 2 to 5, 2019 in Toronto, Canada.

May 6, 2019
·
4 min read
Publications of Secarna Pharmaceuticals’ immuno-oncology data in peer-reviewed scientific journals support potential of LNAplusTM antisense oligonucleotide platform for discovering novel cancer therapies

New strategies urgently needed to prevent tumors from evading the immune system and to make them more susceptible to attack by immune cells

May 6, 2019
·
6 min read
Drug Development

Cytokinetics’ ALS Treatment Fails to Hit Endpoints in Phase II, Company Notes Several Positive Results

Despite not hitting endpoints, Cytokinetics noted that the FORTITUDE-ALS trial demonstrated consistency of effect for doses, endpoints and timepoints.

May 6, 2019
·
3 min read
·
Alex Keown
Bio NC

Your Feedback Matters! The Right Opportunity

As a valued member of our BioSpace community, we are eager to hear more from you and other readers in 2019. We want to know your ‘right opportunity’ to consider a new job.

May 6, 2019
·
1 min read
·
Editorial Staff
Biovica: Positive DiviTum® Study Results Published in Highly-renowned European Journal of Cancer

The strong results from the previously presented EFECT study have now been published in the scientific, and highly renowned, European Journal of Cancer (impact factor 7.191 which equals to top 3% of scientific journal ranking)

May 6, 2019
·
2 min read
Drug Development

Safety and Efficacy Data From the MIV-711 Phase II Open Label Extension Study Presented at the OARSI World Congress

Medivir AB informs that new data from the phase II program of MIV-711, has been presented as a poster during the Osteoarthritis Research Society International world congress.

May 6, 2019
·
3 min read
Policy

Does your Dog Have Itchy Ears?

Does your dog shake their head frequently, scratch incessantly at their ears or have smelly, dirty or itchy ears? In dogs, allergies can appear as ear infections and can be recurrent and hard to get rid of.

May 6, 2019
·
2 min read
Business

Dubai Science Park Signs Partnership Agreement With US Venture Capital Firm 1792 Partners to Attract American Science Companies to Dubai

Agreement Signed During High-level Business Mission to California led by Dubai Investment Development Agency, Dubai Exports

May 6, 2019
·
5 min read